Photrexa Cross-linking Kit

Glaukos Corporation🇺🇸 United States

FDA Page

Effective Date: Jul 24, 2026
Approval ID: f82cfe92-1a24-11e3-8ffd-0800200c9a66
Products: 3 registered
Version: 26

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use PHOTREXA VISCOUS and PHOTREXA safely and effectively. See full prescribing information for PHOTREXA VISCOUS and PHOTREXA. PHOTREXA VISCOUS (riboflavin 5'-phosphate in 20% dextran ophthalmic solution) 0.146% for topical ophthalmic use PHOTREXA (riboflavin 5'-phosphate ophthalmic solution) 0.146% for topical ophthalmic use For use with the KXL System Initial U.S. Approval: 2016

Quick Stats

Total Products3

Labelers2

Label Sections33

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.